SCHEMBL3660163

SCHEMBL3660163

O=C(NC1CCN(Cc2ccncc2)C(I)C1)c1cc(OC2CCN(c3ccc(C(F)(F)F)cc3)CC2)ccn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.39
EPHX2 P34913 4/20 0.38
RAF1 P04049 2/20 0.38
BRAF P15056 1/20 0.38
SLC6A5 Q9Y345 3/20 0.37
RORC P51449 1/20 0.37
MDM2 Q00987 2/20 0.36
DRD4 P21917 1/20 0.36
PRKAA2 P54646 2/20 0.36
LPL P06858 1/20 0.36
LIPG Q9Y5X9 1/20 0.36
KCNH2 Q12809 2/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
OPRK1 P41145 1/20 0.36
P2RX3 P56373 1/20 0.36
CSF1R P07333 1/20 0.35
FLT3 P36888 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3666697 0.94 PRKAA2 (0.43) F10EPHX2RAF1BRAFSLC6A5
SCHEMBL3664005 0.92 PRKAA2 (0.45) EPHX2RORCPRKAA2
SCHEMBL4441003 0.88 DRD4 (0.43) F10SLC6A5DRD4KCNH2OPRK1
SCHEMBL648255 0.88 SLC6A5 (0.49) SLC6A5DRD4PRKAA2KCNH2
SCHEMBL3664555 0.87 MEN1 (0.40) F10SLC6A5RORCMDM2DRD4
SCHEMBL3666588 0.87 SSTR5 (0.42) F10SLC6A5RORCDRD4PRKAA2
SCHEMBL3667429 0.86 SLC6A4 (0.40) F10SLC6A5DRD4PRKAA2LPL
SCHEMBL3662737 0.85 MDM2 (0.41) F10SLC6A5MDM2DRD4PRKAA2
SCHEMBL3663620 0.85 UTS2R (0.41) F10SLC6A5DRD4
SCHEMBL3666339 0.85 SLC6A4 (0.40) F10SLC6A5DRD4PRKAA2CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231600-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS Rigel Pharmaceuticals, Inc. (US) 2010-09-29 EP claimed
WO-2009065131-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS RIGEL PHARMACEUTICALS, INC. (US) 2009-05-22 WO claimed